Nektar Therapeutics
NKTR
NKTR
237 hedge funds and large institutions have $949M invested in Nektar Therapeutics in 2022 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 88 increasing their positions, 64 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
237
Holders Change
-1
Holders Change %
-0.42%
% of All Funds
3.75%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
42
Increased
88
Reduced
64
Closed
40
Calls
$31.5M
Puts
$38M
Net Calls
-$6.52M
Net Calls Change
-$15.9M
Top Buyers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$5.23M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.95M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$4.68M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.46M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$3.7M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$35.1M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$13.3M |
| 3 |
MCM
M28 Capital Management
Stamford,
Connecticut
|
-$7.57M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$5.55M |
| 5 |
BlackRock
New York
|
-$3M |
